SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

US FDA approves Eli Lilly’s advanced breast cancer drug combo

Eli Lilly said the US FDA has approved its drug combination to treat adults with advanced breast cancer that has spread to other parts of the body.

LLY

The US FDA has approved Eli Lilly's NYSE:LLY drug combination to treat adults with a type of advanced breast cancer that has spread to other parts of the body, the drugmaker said on Friday.Here are some details

Related stories